A Study to Determine the Movement of Radiolabelled PF-07304814 Through the Body in Healthy Participants
A Study to Determine the Movement of Radiolabelled PF-07304814 Through the Body in Healthy
Participants. A Phase 1, Open-Label, Single-Dose Study to Investigate the Mass Balance, Metabolism and Excretion of [14C]-PF-07304814 in Healthy Participants Using a 14C-Microtracer Approach.
Category & Conditions: Coronavirus Disease (COVID-19)
Medicine: PF-07304814
ClinicalTrials.gov Identifier (NCT): NCT05050682
Protocol ID: C4611003
PrintDownloadOpen Plain Language Summary Result: Click here